WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992000754) IGF-1 AND RELATED COMPOUNDS IN PREGNANCY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/000754    International Application No.:    PCT/AU1991/000309
Publication Date: 23.01.1992 International Filing Date: 10.07.1991
Chapter 2 Demand Filed:    10.02.1992    
IPC:
A61K 38/30 (2006.01)
Applicants: AUCKLAND UNISERVICES LIMITED [NZ/NZ]; Level 6, 20 Symonds Street, Auckland (NZ) (For All Designated States Except US).
GLUCKMAN, Peter, David [NZ/NZ]; (NZ).
AMBLER, Geoffrey, Richard [AU/NZ]; (NZ).
BREIER, Bernhard, Heinrich [DE/NZ]; (NZ)
Inventors: GLUCKMAN, Peter, David; (NZ).
AMBLER, Geoffrey, Richard; (NZ).
BREIER, Bernhard, Heinrich; (NZ)
Agent: F.B. RICE & CO.; 28A Montague Street, Balmain, NSW 2041 (AU)
Priority Data:
234439 10.07.1990 NZ
Title (EN) IGF-1 AND RELATED COMPOUNDS IN PREGNANCY
(FR) IGF-1 ET COMPOSES ANALOGUES DANS LA GESTATION
Abstract: front page image
(EN)Fetal growth is promoted, and fetal growth retardation is reduced, in mammals by increasing in a maternal host during pregnancy the active concentration of IGF-1 and/or IGF-2 and/or analogues thereof. The active concentration of IGF-1 and/or IGF-2 and/or analogues thereof may be increased by administering such a compound to the maternal host, or by administering to the maternal host a compound, such as placental lactogen, which upon being so administered increases the active concentration of IGF-1 and/or IGF-2 and/or analogues thereof in the maternal host.
(FR)On active la croissance f÷tale et on diminue le retard de la croissance f÷tale chez les mammifères en augmentant, pendant la gestation, la concentration active de IGF-1 et/ou IGF-2 et/ou de leurs analogues chez une femelle. On peut augmenter la concentration active de IGF-1 et/ou IGF-2 et/ou de leurs analogues en administrant ce composé à une femelle ou en lui administrant un composé tel que le lactogène placentaire, qui, de ce fait augmente la concentration active de IGF-1 et/ou IGF-2 et/ou de leurs analogues chez la femelle.
Designated States: AT, AU, BB, BG, BR, CA, CH, DE, DK, ES, FI, GB, HU, JP, KP, KR, LK, LU, MC, MG, MW, NL, NO, PL, RO, SD, SE, SU, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)